Investment Trusts

Target Healthcare REIT plc

THRL:LSE

Target Healthcare REIT plc

Actions
  • Price (GBX)70.10
  • Today's Change0.50 / 0.72%
  • Shares traded1.97m
  • 1 Year change-37.85%
  • Beta0.4612
Data delayed at least 20 minutes, as of Mar 31 2023 16:38 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PriceTarget Healthcare REIT plc (Ordinary Share)-25.67%
NAVTarget Healthcare REIT plc (Ordinary Share)+5.24%
Morningstar's BenchmarkFTSE EPRA Nareit UK TR GBP--

Key statistics

On Friday, Target Healthcare REIT plc (THRL:LSE) closed at 70.10, 6.70% above its 52-week low of 65.70, set on Mar 28, 2023.
52-week range
Today
65.70Mar 28 2023120.68Jun 06 2022
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding620.24m
Market cap444.09m GBP
Total assets855.69m GBP
Total expense ratio1.52%
High70.70
Low69.20
Previous close69.60
Average volume2.05m
YTD Change-12.59%
Beta0.4612
Diluted NAV (est)102.66
Diluted NAV (last pub)103.00
Premium/Discount-29.19%
Net Gearing+28.13%
Annual div (ADY)6.76
GBX
Annual div yield (ADY)9.64%
Div ex-dateFeb 09 2023
Div pay-dateFeb 24 2023
Data delayed at least 20 minutes, as of Mar 31 2023 16:38 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.